Institutional investors purchased a net $29.1 thousand shares of MBOT during the quarter ended September 2016. This may signal that the smart money is gaining interest in this company as the 0.47% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GEODE CAPITAL MANAGEMENT LLC Bought 15.5 Thousand shares of Microbot Medical Inc
MILLENNIUM MANAGEMENT LLC Bought 15.3 Thousand shares of Microbot Medical Inc
CITADEL ADVISORS LLC Bought 11.1 Thousand shares of Microbot Medical Inc